Study to Reduce Intravenous Exposures (STRIVE)
Funded by: National Institute on Drug Abuse
Project dates: September 2001 - August 2006
Principal Investigator: Hagan, Holly (Seattle PI)

HCV is one of the most frequently occurring human viral infections, especially among drug users. The study determined whether a new peer education intervention was effective in reducing HCV transmission by people who inject drugs (PWID) who are infected with HCV.  It also evaluated whether the intervention increased the use of HCV-related healthcare services among HCV-infected PWID. Results of the study will help inform policy decisions, including guidelines for HCV treatment, with the goal of decreasing high risk transmission behaviors and increasing access to care.

Abstract on NIH RePORTER
Related Publications
Latka MH, Hagan H, Kapadia F, Golub ET, Bonner S, Campbell JV, Coady MH, Garfein RS, Pu M, Thomas DL, Thiel TK, Strathdee SA (2008).
A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C
American Journal of Public Health, 98 (5), 853-861. doi: 10.2105/AJPH.2007.113415. PMCID: PMC2374802.

Kapadia F, Latka MH, Hagan H, Golub ET, Campbell JV, Coady MH, Garfein RS, Thomas DL, Bonner S, Thiel T, Strathdee SA (2007).
Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health-care access among hepatitis C virus positive injection drug users: The Study to Reduce Intravenous Exposures (STRIVE)
Journal of Urban Health, 84 (1), 99-115. doi: 10.1007/s11524-006-9133-7. PMCID: PMC2078252.

Campbell JV, Hagan H, Latka MH, Garfein RS, Golub ET, Coady MH, Thomas DL, Strathdee SA, STRIVE Project (2006).
High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities
Drug and Alcohol Dependence, 81 (3), 259-265. doi: 10.1016/j.drugalcdep.2005.07.005. PMCID: PMC2196223.

Hagan H, Latka MH, Campbell JV, Golub ET, Garfein RS, Thomas DA, Kapadia F, Strathdee SA, Study to Reduce Intravenous Exposures Project Team (2006).
Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities
Clinical Infectious Diseases, 42 (5), 669-672. doi: 10.1086/499951.

Strathdee SA, Latka M, Campbell J, Driscoll PT, Golub ET, Kapadia F, Pollini RA, Garfein RS, Thomas DL, Hagan H (2005).
Factors associated with interest in initiating treatment for hepatitis C virus (HCV) infection among young HCV-infected injection drug users
Clinical Infectious Diseases, 40 (Suppl 5), S304-S312. doi: 10.1086/427445. PMCID: PMC2196220 .